Martin Henry Poleski

Professor of Medicine
Campus mail 0351D Duke South Bldg, Orange Zone, Durham, NC 27710
Phone (919) 684-1817
In Their Words

Education and Training

  • Fellow in Gastroenterology, Medicine, Memorial Sloan Kettering Cancer Center, 1976 - 1978
  • Medical Resident, Medicine, Jewish Hospital (Canada), 1974 - 1976
  • M.D.C.M., McGill University (Canada), 1973

Publications

Cardona, DM, Detweiler, CJ, Shealy, MJ, Sung, AD, Wild, DM, Poleski, MH, Balmadrid, BL, Cirrincione, CT, Howell, DN, and Sullivan, KM. "Use of the National Institutes of Health Consensus Guidelines Improves the Diagnostic Sensitivity of Gastrointestinal Graft-Versus-Host Disease." Archives of Pathology & Laboratory Medicine 142, no. 9 (September 2018): 1098-1105.

PMID
29697275
Full Text

Sung, AD, Hassan, S, Cardona, DM, Wild, D, Nichols, KR, Mehdikhani, H, Balmadrid, B, Detweiler, CJ, Shealy, M, Cirrincione, C, Li, Z, Poleski, M, Dalton, TE, Siamakpour-Reihani, S, Chao, NJ, and Sullivan, KM. "Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Adults." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 24, no. 4 (April 2018): 734-740.

PMID
29246821
Full Text

Wild, D, Sung, AD, Cardona, D, Cirricione, C, Sullivan, K, Detweiler, C, Shealy, M, Balmadrid, B, Rowes, KL, Chao, N, Piryani, S, Karimabad, HM, Martin, P, and Poleski, M. "The Diagnostic Yield of Site and Symptom-Based Biopsies for Acute Gastrointestinal Graft-Versus-Host Disease: A 5-Year Retrospective Review." Digestive Diseases and Sciences 61, no. 3 (March 2016): 806-813.

PMID
26537485
Full Text

Coutré, SE, Barrientos, JC, Brown, JR, de Vos, S, Furman, RR, Keating, MJ, Li, D, O'Brien, SM, Pagel, JM, Poleski, MH, Sharman, JP, Yao, N-S, and Zelenetz, AD. "Management of adverse events associated with idelalisib treatment: expert panel opinion." Leukemia & Lymphoma 56, no. 10 (January 2015): 2779-2786. (Review)

PMID
25726955
Full Text

Shah, TU, Liddle, R, Branch, MS, Jowell, P, Obando, J, and Poleski, M. "Pilot study of aprepitant for prevention of post-ERCP pancreatitis in high risk patients: a phase II randomized, double-blind placebo controlled trial." Jop : Journal of the Pancreas 13, no. 5 (September 10, 2012): 514-518.

PMID
22964958
Full Text

Faes, SK, Untch, BR, Edwards, C, Turner, J, Poleski, M, and Tyler, DS. "Management of Dieulafoy’s Lesions." (2010): 31-37.

Full Text

Willett, CG, Duda, DG, Ancukiewicz, M, Shah, M, Czito, BG, Bentley, R, Poleski, M, Fujita, H, Lauwers, GY, Carroll, M, Tyler, D, Mantyh, C, Shellito, P, Chung, DC, Clark, JW, and Jain, RK. "A safety and survival analysis of neoadjuvant bevacizumab with standard chemoradiation in a phase I/II study compared with standard chemoradiation in locally advanced rectal cancer." Oncologist 15, no. 8 (2010): 845-851.

PMID
20667969
Full Text

Duda, DG, Willett, CG, Ancukiewicz, M, di Tomaso, E, Shah, M, Czito, BG, Bentley, R, Poleski, M, Lauwers, GY, Carroll, M, Tyler, D, Mantyh, C, Shellito, P, Clark, JW, and Jain, RK. "Plasma soluble VEGFR-1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancer." Oncologist 15, no. 6 (2010): 577-583.

PMID
20484123
Full Text

Xu, L, Duda, DG, di Tomaso, E, Ancukiewicz, M, Chung, DC, Lauwers, GY, Samuel, R, Shellito, P, Czito, BG, Lin, P-C, Poleski, M, Bentley, R, Clark, JW, Willett, CG, and Jain, RK. "Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer." Cancer Res 69, no. 20 (October 15, 2009): 7905-7910.

PMID
19826039
Full Text

Willett, CG, Duda, DG, di Tomaso, E, Boucher, Y, Ancukiewicz, M, Sahani, DV, Lahdenranta, J, Chung, DC, Fischman, AJ, Lauwers, GY, Shellito, P, Czito, BG, Wong, TZ, Paulson, E, Poleski, M, Vujaskovic, Z, Bentley, R, Chen, HX, Clark, JW, and Jain, RK. "Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study." J Clin Oncol 27, no. 18 (June 20, 2009): 3020-3026.

PMID
19470921
Full Text

Pages